Captrust Financial Advisors Acura Pharmaceuticals, Inc Transaction History
Captrust Financial Advisors
- $30.9 Billion
- Q2 2024
About ACURA PHARMACEUTICALS, INC
- Ticker ACUR
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 65,089,000
- Description
- Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed...